Free shares | LTIP 2019(1) | Sapient 2019 (3 years)(2) | Sapient 2019 (4 years) | LTIP 2021- 2021 “Directoire” (2) | Star Growth Performers/ Special 2019 Plan | Epsilon Replacement Plan 2019(2)(3) | Special Retention Plan 2019(2) | |
|---|---|---|---|---|---|---|---|---|
Free shares Date of Management Board meeting | LTIP 2019(1) 28/05/2019 | Sapient 2019 (3 years)(2) 28/05/2019 | Sapient 2019 (4 years) 28/05/2019 | LTIP 2021- 2021 “Directoire” (2) 14/06/2019 | Star Growth Performers/ Special 2019 Plan 28/05/2019 | Epsilon Replacement Plan 2019(2)(3) 15/07/2019 (3) | Special Retention Plan 2019(2) 15/11/2019 | |
Free shares Number of shares originally granted | LTIP 2019(1) 335,950 | Sapient 2019 (3 years)(2) 345,289 | Sapient 2019 (4 years) 240,210 | LTIP 2021- 2021 “Directoire” (2) 170,000 | Star Growth Performers/ Special 2019 Plan 262,700 | Epsilon Replacement Plan 2019(2)(3) 628,681 | Special Retention Plan 2019(2) 765,110 | |
Free shares Initial valuation of shares granted (weighted average, in euros) | LTIP 2019(1) 42.81 | Sapient 2019 (3 years)(2) 42.81 | Sapient 2019 (4 years) 43.95 | LTIP 2021- 2021 “Directoire” (2) 43.29 | Star Growth Performers/ Special 2019 Plan 42.81 | Epsilon Replacement Plan 2019(2)(3) 45.67 | Special Retention Plan 2019(2) 31.85 | |
Free shares Share price on the grant date (in euros) | LTIP 2019(1) 49.66 | Sapient 2019 (3 years)(2) 49.66 | Sapient 2019 (4 years) 49.66 | LTIP 2021- 2021 “Directoire” (2) 50.14 | Star Growth Performers/ Special 2019 Plan 49.66 | Epsilon Replacement Plan 2019(2)(3) 48.03 | Special Retention Plan 2019(2) 39.21 | |
Free shares Vesting period (in years) | LTIP 2019(1) 3 | Sapient 2019 (3 years)(2) 3 | Sapient 2019 (4 years) 1 à 4 | LTIP 2021- 2021 “Directoire” (2) 3 | Star Growth Performers/ Special 2019 Plan 3 | Epsilon Replacement Plan 2019(2)(3) 1, 2 and 3 | Special Retention Plan 2019(2) 3 |
(1) Conditional shares whose vesting is subject to the achievement of targets set for the year 2019.
(2) Conditional shares whose vesting is subject to the achievement of targets set for the years 2019 to 2021 or, in the case of the Special Retention Plan, for the years 2020 to 2022.
(3) The Management Board meeting of July 15, 2019 only granted the first third of plan shares, namely 207,461 shares. Two other tranches comprising 207,461 and 213,759 shares, respectively, will be granted by the Management Board at its meetings in March 2020 and March 2021.
The total impact of these plans on the 2019 income statement was euro 49 million (excluding taxes and social security charges), compared to euro 63 million in 2018 (see Note 3 “Personnel expenses”).
With regard to the free share plans granted subject to non-market performance conditions, and for which performances have not yet been definitively measured as of December 31, 2019, the probability of meeting the targets set in respect of the calculation of the 2019 expense has been estimated as follows:
The condition for achieving the organic growth target (2018- 2020 average) cannot be satisfied given the performance levels already recorded for 2018 and 2019. Failure to satisfy this condition results in a loss of all entitlement to shares awarded at the outset of the plan (save any contractual provision to the contrary).
